Hostname: page-component-74656f9884-skzmx Total loading time: 0 Render date: 2026-11-06T00:39:54.962Z Has data issue: false hasContentIssue false

Porphyrin-based nanocomposites for tumor photodynamic therapy

Published online by Cambridge University Press:  11 March 2019

Weitao Yang
Affiliation:
Institute of Photomedicine, Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering and Nano Science, Tongji University School of Medicine, China; weitaoyang@tongji.edu.cn
Bingbo Zhang
Affiliation:
Institute of Photomedicine, Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering and Nano Science,Tongji University School of Medicine, China; bingbozhang@tongji.edu.cn

Abstract

Porphyrins and their associated derivatives have been widely used as photosensitizers for photodynamic therapy (PDT) of tumors. To overcome the limitations of porphyrin photosensitizers in PDT, the marriage of porphyrins and nanotechnology offers a new perspective to improve the efficacy and safety of porphyrin-based PDT. To date, various organic and inorganic nanoparticles have been developed for porphyrin delivery for high payload photosensitizers, protection from premature release of photosensitizers, and tumor-selective targeting. In this article, we summarize the strategies for porphyrin photosensitizer delivery, including encapsulation, covalent conjugation, self-assembly for PDT, and characterization methods of singlet oxygen (1O2) generation. We focus on the summarized strategies of improving cancer PDT efficacy by nanotechnology. Finally, the challenges and outlook for porphyrin-based nanocomposites-mediated PDT are discussed.

Information

Type
Self-Assembled Porphyrin and Macrocycle Derivatives
Copyright
Copyright © Materials Research Society 2019 
Figure 0

Figure 1. Nanoparticle-mediated porphyrin delivery strategies, including encapsulation (mesoporous silica nanoshells,[MSNs],8 metal–organic frameworks [MOFs],9 polymeric micelles,10 and liposomes11), covalent conjugation (poly(lactic-co-glycolic acid) [PLGA]),12 AuNPs,13 Fe3O4,14 and lipid microbubbles15), and self-assembly (ZnTPP/SiO216 and ZnTPyP@NO17). Note: ZnTPP, zinc-tetra (4-pyridyl) porphyrin; ZnTPyP, zinc meso-tetra(4-pyridyl)porphyrin; NO, nitrous oxide; PPIX, protoporphyrin IX; NP, nanoparticle; 1O2, singlet oxygen.

Figure 1

Figure 2. Porphyrin-based photoconversion nanoparticles for enhanced photodynamic therapy. (a) Schematic illustration of porphyrin-based upconversion nanoparticles (UCNPs) for singlet oxygen (1O2) generation by converting near-infrared (NIR) light to visible light. (b) Absorbance spectrum of meso-tetraphenylporphine (TPP) and fluorescence spectrum of UCNPs irradiated by NIR light (978 nm). The NIR light was effectively converted to visible light (500–600 nm) for TPP excitation due to overlap of fluorescence emission and absorption spectra.27 (c) Schematic illustration of porphyrin-based nanoscintillator for 1O2 generation by converting x-rays to visible light.29 (d) Absorbance spectrum of PPIX and fluorescence spectrum of LaF3:Ce/PLGA nanoscintillator irradiated by x-rays. The x-rays were successfully converted to green light (emission peak: 520 nm) for PPIX excitation due to overlap of fluorescence emission and absorption spectra.30 Note: PLGA, poly(lactic-co-glycolic acid); ET, excitation; PPIX, protoporphyrin IX; ScNPs, scintillating nanoparticles.

Figure 2

Figure 3. Enhancing photodynamic therapy (PDT) efficacy by relieving tumor hypoxia, including (a, b) O2 delivery and (c, d) O2 generation in situ. (a) Photoacoustic (PA) images of THPPpf-PEG and PFCE@THPPpf-PEG under the oxy-hemo mode. The red dashed circle indicates the region of interest for quantitative analysis of PA signal intensity. The tumor oxygenation of the (lower row) mice given an intravenous injection of PFCE@THPPpf–PEG (4 h p.i. and 24 h p.i.) was significantly increased compared to (upper row) the group given the THPPpf-PEG injection. Note: p.i., post injection; color bar (high and low), photoacoustic signal intensity. (b) Immunofluorescence staining images of tumor slices after intravenous injection of THPPpf-PEG and PFCE@THPPpf-PEG. The hypoxia areas and blood vessels were stained with (top) antipimonidazole antibody (green) and (middle) anti-CD31 antibody (red). (Bottom) Combination of the two images. Tumor hypoxia signals of the mice with intravenous injection of PFCE@THPPpf-PEG (4 h p.i. and 24 h p.i.) were significantly attenuated compared to the group given THPPpf-PEG.31 (c) Immunofluorescence staining images (HIF-1α and VEGF) of tumor tissues after intravenous injection of PCN-224 and PCN-224-Pt. The tumors injected with PCN-224-Pt showed significantly weakened tumor hypoxia compared to those that received the PCN-224 injection, which is evidenced by the greatly decreased immonufluorescence intensity of HIF-1α and VEGF. (d) Tumor dissection images of different groups (control, saline injection + light irradiation, PCN-224 injection, PCN-224-Pt injection, PCN-224 injection + light irradiation, and PCN-224-Pt injection + light irradiation). The steel ruler was used to identify the tumor size. The tumor growth was completely inhibited with the injection of PCN-224-Pt after laser irradiation treatment due to O2-enhanced PDT.32 Note: THPPpf, meso-5,10,15,20-tetra (4-hydroxylphenyl)porphyrin (THPP) + perfluorosebacic acid; PEG, poly(ethylene glycol); PFCE, perfluoro-15-crown-5-ether; HIF, hypoxia inducible factor; VEGF, vascular endothelial growth factor; PCN, porous coordination network.

Figure 3

Figure 4. (a) In vivo positron emission tomography (PET) imaging of 4T1 tumor-bearing mice at different points in time after intravenous injection of 64Cu-TCPP-PEG2K,TCPP-PEG5K,TCPP-PEG10K, and TCPP-PEG30K). TCPP-PEG nanoparticles with higher molecular weights (TCPP-PEG10K and TCPP-PEG30K) showed higher tumor uptake efficacy. (b) In vivo fluorescence imaging of 4T1 tumor-bearing mice at different points in time (0.5 h, 4 h, 12 h, and 24 h) after intravenous injection of 64Cu-TCPP-PEG10K. TCPP-PEG10K nanoparticles were able to be cleared and the prominent tumor uptake time is 24 h after injection. (c) Tumor growth curves, (d) tumor weight, and (e) hematoxylin-eosin staining images of mice in different groups (control, laser only, 64Cu-TCPP-PEG10K only, and 64Cu-TCPP-PEG10K+laser).36 The tumor growth of 64Cu-TCPP-PEG10K+laser group was significantly inhibited, and tumor cells were killed and cell apoptosis was found. Note: TCPP, tetrakis (4-carboxyphenyl) porphyrin; PEG, poly(ethylene glycol); %ID, percentage injected dose.